Empagliflozin
Overview
Empagliflozin is an oral sodium-glucose co-transporter 2 (SGLT2) inhibitor. It is prescribed for adults with type 2 diabetes to improve glycaemic control and has notable cardiovascular and renal protective benefits, including reducing the risk of cardiovascular death and hospital admissions for heart failure.
Mechanism of Action
It inhibits SGLT2, the primary transporter responsible for glucose reabsorption in the proximal renal tubules. By blocking this transporter, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, thereby increasing urinary glucose excretion and lowering blood glucose levels independently of insulin.
Dosage and Administration
The recommended starting dose is 10 mg once daily in the morning, taken with or without food. In patients tolerating the drug well, the dose may be increased to 25 mg daily for additional glycaemic control. Adequate renal function is required for it to be effective.
Side Effects
Common side effects include fungal infections of the genitals (such as thrush and balanitis), urinary tract infections, and increased urination. It can cause a reduction in the amount of fluid in the blood, leading to low blood pressure. A rare but serious risk is ketoacidosis that occurs when blood sugar levels are normal.
Contraindications
It is contraindicated in patients with a history of serious hypersensitivity to empagliflozin and in patients on dialysis. It is not indicated for type 1 diabetes.
Pregnancy and Lactation
Empagliflozin is not recommended during the second and third trimesters of pregnancy due to potential adverse effects on fetal renal development. It is also not recommended during breastfeeding.
The medication usage, medical information, and related content provided on this website are for general informational purposes only. Under no circumstances should they be considered a substitute for professional medical advice, diagnosis, or treatment plans. Users must consult a registered doctor, pharmacist, or other qualified healthcare professional before making any medical decisions. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Do not use the information provided here to self-diagnose or treat any health issues or diseases.
Statement on Information Sources and Objectivity
The medical information and content presented on this website are based on widely recognised medical knowledge and public literature, and have been retrieved, translated, and compiled with the assistance of artificial intelligence (AI) tools. Details regarding disease symptoms, drug indications, mechanisms of action, and side effects are objective medical facts intended purely for general public education and reference.
Limitation of Liability
This website, and those who operate it, accept no legal liability for any of the following:
- Any direct or indirect consequences arising from a user's use of, or reliance on, the information provided on this website.
- Any adverse reactions, side effects, or other impacts resulting from the use of medications or treatments mentioned on this website.
- The accuracy, completeness, or timeliness of the information provided on this website (including content retrieved and compiled via AI).
If you are experiencing a medical emergency, please seek immediate professional medical assistance or call emergency services.